[Experimental rationale for the use of T-activin for correction of immunodeficiency in the treatment of periapical inflammation].
Volozhin
A I
AI
Arion
V Ia
VIa
Zyrianov
G V
GV
Krotova
S B
SB
Sysoeva
O B
OB
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000818:Animals; D004285:Dogs; D016867:Immunocompromised Host / Q000187:drug effects*; D010455:Peptides / Q000627:therapeutic use*; D010485:Periapical Periodontitis / Q000188:drug therapy* / Q000276:immunology; D051381:Rats; D013949:Thymus Extracts / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D010455:Peptides; D013949:Thymus Extracts; C036191:T-activin
Eksperimental'noe obosnovanie primeneniia taktivina dlia korrektsii immunodefitsitnogo sostoianiia pri lechenii periapikal'nogo vospaleniia.